Our leadership team – Sumit Jamuar, Saumya Jamuar, Jonathan Picker and Yaron Turpaz – have an in-depth feature in the latest edition of Drug Discovery World, exploring the importance of incorporating genomic diversity into the drug discovery process.
“The publication of the first human genome sequence more than 15 years ago marked the start of a new era in medicine. In the years since then, researchers have greatly expanded knowledge of gene-disease links and gained a better understanding of the underlying molecular pathways.
The first precision therapies, targeted to specific molecular alterations, are already available. Despite this progress, the lack of diversity in genetic databases limits the potential benefits and markets for these advances. To further grow the field of precision medicine, much more knowledge is needed of the global diversity found in the human genome.”